Laverdia® is the only FDA-approved
oral treatment for canine lymphoma.

The First Step

Happens at Home

Take action with Laverdia®

There’s something meaningful you can do for your dog, and it can start today with Laverdia®

  • Laverdia® is the only FDA-approved oral treatment for lymphoma in dogs
  • It’s a tablet given twice a week at home

Laverdia® offers targeted
treatment from the start

Laverdia® kills lymphoma cells and can help slow the progression of cancer. As a targeted treatment, it generally spares healthy cells.1

Laverdia cartons and bottles

Laverdia® can meet you
where you are

When your dog is just diagnosed: You can start giving Laverdia® on Day 1.
While you’re waiting on next steps: Laverdia® gives you a way to start treatment while waiting for a referral, oncology appointment, or multi-agent chemotherapy.
After relapse: Treatment doesn’t have to stop—Laverdia® can be used after relapse.
When multi-agent chemotherapy isn’t the path for you: Laverdia® can give you and your dog meaningful time at home when multi-agent chemotherapy isn’t an option or isn’t what you want right now.
Dog resting in bed

Canine lymphoma moves fast

That’s why early action is critical

If your dog has lymphoma,

ask your veterinarian about Laverdia®.

Veterinary professionals can speak with the Dechra Medical Consult and Product Support Team for case consultations:
Phone: 1-866-933-2472  •  Email: support@dechra.com

Reference: 1. Laverdia® [prescribing information]. Overland Park, KS: Dechra Veterinary Products LLC; 2026.

Important Safety Information

For oral use in dogs only. Do not use in dogs that are pregnant, nursing puppies, or intended for breeding. Laverdia® can cause birth defects and can affect female and male fertility. Laverdia® can cause severe anorexia. Dogs should be carefully monitored for the most commonly reported adverse reactions including decrease/loss of appetite, vomiting, diarrhea, dehydration, weight loss, excessive urination, excessive thirst, elevated liver enzymes and low blood platelet count, and additional care by a veterinarian may be necessary if these side effects occur. Frequent check-ups by your veterinarian are necessary to determine whether your dog is responding to treatment, and to decide whether your dog should continue treatment with Laverdia®. NOT FOR USE IN HUMANS. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. CHILDREN SHOULD NOT COME INTO CONTACT WITH LAVERDIA®. Pregnant women, women who may become pregnant, nursing women and children should not handle or administer Laverdia® or come into contact with the feces, urine, saliva, or vomit of Laverdia®-treated dogs. Wear protective disposable chemotherapy resistant gloves when handling Laverdia® to prevent direct contact with moistened, broken or crushed tablets and when handling feces, urine, saliva, or vomit or items that have come in contact with the treated dog during treatment and for 3 days after the last treatment. Please see Client Information Sheet and package insert or visit dechra-us.com for full product information.